Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Celecoxib with FOLFERI in metastatic colorectal cancer
NCT03645187Phase 4Recruiting
- Start
- Aug 2018
- Primary completion
- Aug 2025
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised trial of celecoxib in metastatic colorectal cancer (mCRC) (2 arms). Primary endpoint: Number of patients with improved radiology at 6 months. Started Aug 2018; status: recruiting.
02
Drugs
celecoxib
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT03645187.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03645187.